P10721 (KIT_HUMAN) Homo sapiens (Human)
Mast/stem cell growth factor receptor Kit UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
42 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Ectodomain of full-length wild-type KIT-SCF dimers |
Heteromer P21583; | 100.0 | 4×NAG; 2×NAG; | |||
| Crystal structure of the extracellular domain of Kit in complex with stem cell factor (SCF) |
Heteromer P21583; | 99.57 | 6×NAG; | |||
| Ectodomain of full-length KIT(T417I,delta418-419)-SCF dimers |
Heteromer P21583; | 99.74 | 3×NAG; 1×NAG; | |||
| Ectodomain of full-length KIT(DupA502,Y503)-SCF dimers |
Heteromer P21583; | 100.0 | 4×NAG; 2×NAG; | |||
| Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibody Fab19 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibodies Fab79D |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SOCS6 SH2 domain in complex with a c-KIT phosphopeptide |
Heteromer O14544; | 100 | 1×EDO; | |||
| Crystal structure of the PI3-kinase p85 N-terminal SH2 domain in complex with c-Kit phosphotyrosyl … |
Heteromer P27986; | 100 | ||||
| KIT kinase domain mutant D816H in complex with sunitinib | homo-4-mer | 100.0 | 4×B49; 2×SO4; | |||
| Crystal structure of human c-KIT kinase domain in complex with compound 15a | homo-2-mer | 100.0 | 2×DJX; | |||
| Crystal structure of unactivated c-KIT in complex with compound | homo-2-mer | 100.0 | 2×AWO; | |||
| Crystal structure of activated c-KIT in complex with compound | homo-2-mer | 100.0 | 2×AWO; | |||
| Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zip… | homo-2-mer | 99.08 | 2×NAG; 4×CO; | |||
| Crystal structure of the exctracellular domain of the receptor tyrosine kinase, Kit | monomer | 100.0 | 5×NAG; | |||
| STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE | monomer | 100 | ||||
| KIT kinase domain in complex with sunitinib | monomer | 100 | 1×B49; | |||
| Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX3397 | monomer | 93.01 | 1×P31; | |||
| Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647 | monomer | 92.41 | 1×647; | |||
| Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic … | monomer | 100.0 | 1×K3R; | |||
| Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic … | monomer | 100.0 | 1×KCI; | |||
| STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE | monomer | 100.0 | 2×PO4; 1×STI; | |||
| Crystal structure of KIT in complex with ponatinib | monomer | 100.0 | 1×0LI; 2×PO4; | |||
| c-KIT kinase domain in complex with avapritinib derivative 9 | monomer | 95.9 | 1×9OO; | |||
| c-KIT kinase domain in complex with avapritinib derivative 10 | monomer | 95.9 | 1×9VV; | |||
| c-KIT kinase domain in complex with avapritinib | monomer | 95.9 | 1×9JI; | |||
| c-KIT kinase domain in complex with avapritinib derivative 12 | monomer | 95.87 | 1×9KI; | |||
| Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in … | monomer | 95.87 | 1×WEJ; | |||
| c-KIT T670I mutated kinase domain in complex with avapritinib | monomer | 95.08 | 1×9JI; | |||
| Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state | monomer | 95.8 | 1×WEG; | |||
| Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor | monomer | 95.9 | 1×O35; | |||
| c-KIT kinase domain in complex with avapritinib derivative 4 | monomer | 95.9 | 1×98A; | |||
| c-KIT kinase domain in complex with avapritinib derivative 8 | monomer | 95.65 | 1×9XO; | |||
| c-KIT kinase domain in complex with avapritinib derivative 11 | monomer | 95.87 | 1×EDO; 1×9WU; 1×BR; | |||
| Structure of c-Kit with allosteric inhibitor 3G8 | monomer | 95.65 | 1×PO4; 1×G4E; | |||
| Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23) | monomer | 95.87 | 1×F88; | |||
| Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 18) | monomer | 92.91 | 1×F82; | |||
| Crystal structure of KIT1 in complex with DP2976 via co-crystallization | monomer | 100 | 14×NO3; 1×JWY; | |||
| Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35) | monomer | 92.8 | 1×F8B; | |||
| Crystal structure of human c-KIT kinase domain in complex with a small molecule inhibitor, AZD3229 | monomer | 92.74 | 1×F8H; 2×CL; | |||
| Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bo… | monomer | 95.8 | 1×O2H; | |||
| Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing a… | monomer | 95.8 | 1×O2K; | |||
| Structure of a c-Kit Kinase Product Complex | monomer | 100 | 1×MG; 1×ADP; | |||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8dfm.1.A | monomer | 0.75 | 99.89 | |||
| 4hvs.2.B | homo-2-mer | 0.66 | 2×647; | 95.09 | ||
| 3krl.1.A | monomer | 0.62 | 1×KRL; | 67.79 | ||
| 8jot.1.A | monomer | 0.62 | 65.59 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8dfm.1.A | monomer | 0.76 | 99.89 | |||
| Isoform 2 | 8jot.1.A | monomer | 0.63 | 65.59 | |||
| Isoform 2 | 3krl.1.A | monomer | 0.62 | 1×KRL; | 68.10 | ||
| Isoform 4 | 1t45.1.A | monomer | 0.81 | 85.29 | |||